Alzheimer's drug donanemab has been hailed as a 'turning point' for treatment. But what does it mean for people with the disease? - The Conversation
- Alzheimer's drug donanemab has been hailed as a 'turning point' for treatment. But what does it mean for people with the disease? The Conversation
- Alzheimer’s patient: New ‘miracle’ drug has ‘given me my life back’ New York Post
- More developments being made in Alzheimer's research WBAL-TV 11 Baltimore
- Eli Lilly Stock, IBD Stock Of The Day, Breaks Out With Tentpoles In Two Key Markets Investor's Business Daily
- New Alzheimer's treatment: Donanemab drug seen as turning point in fight against disease FRANCE 24 English
- View Full Coverage on Google News